As of late April 2026, Cramer has shifted his focus toward healthcare and "legacy" companies effectively deploying AI.
: Praised for its robust drug pipeline and use of AI in cancer treatments. cramer buy
and Amazon (AMZN) : Labeled as "undervalued" trillion-dollar AI opportunities. Infrastructure & Energy : As of late April 2026, Cramer has shifted